Stéphanie Colloud is General Manager and Chief Operating Officer of ABL’s European activities.
Stéphanie has over 20 years of experience in the life sciences and biologics CDMO industry. Since 2018, as Director of the Lyon site and an Executive Committee Member of ABL Europe, Stéphanie has led the production, quality and technical services departments. Previously, Stéphanie served as Chief Executive Officer at Accinov. She also held several operational roles at PX’Therapeutics, a French biologics CDMO. Stephanie has extensive expertise in process and analytical method development, CMC strategy, a passion for building modular and flexible facilities, and a strong culture of quality and best practices in GMP production.
Stéphanie graduated in Cell Biology Engineering from the Joseph Fourier University of Grenoble, France, and holds a Master’s degree in Quality Management in the Biotech & Biopharma Industry from the Faculty of Pharmacy of Angers, France.